Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Climb Bio (CLYM) Current Leases (2022 - 2026)

Climb Bio filings provide 5 years of Current Leases readings, the most recent being $263000.0 for Q1 2026.

  • Quarterly Current Leases rose 69.68% to $263000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $263000.0 through Mar 2026, up 69.68% year-over-year, with the annual reading at $256000.0 for FY2025, 63.06% up from the prior year.
  • Current Leases hit $263000.0 in Q1 2026 for Climb Bio, up from $256000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $485000.0 in Q2 2023 and bottomed at $58000.0 in Q3 2024.
  • Average Current Leases over 5 years is $288117.6, with a median of $263000.0 recorded in 2026.
  • The largest annual shift saw Current Leases tumbled 85.54% in 2024 before it skyrocketed 293.1% in 2025.
  • Climb Bio's Current Leases stood at $300000.0 in 2022, then rose by 11.33% to $334000.0 in 2023, then plummeted by 52.99% to $157000.0 in 2024, then surged by 63.06% to $256000.0 in 2025, then grew by 2.73% to $263000.0 in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Current Leases are $263000.0 (Q1 2026), $256000.0 (Q4 2025), and $228000.0 (Q3 2025).